Atlas Trials

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

Clinical trial NCT02485028 · COMPLETED

Trial details

NCT number
NCT02485028
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Interaction Potentiation
Start date
2013-10-01
Primary completion
2013-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.